Consolidated Financial Statements for the Second Quarter Ended September 30, 2021 FY2022 (April 1, 2021 – March 31, 2022) [UNAUDITED] | IR News | News Release ＆ IR News | Investor Relations Read more
Brooks Automation Announces Fiscal 2021 Fourth Quarter and Year-End Earnings Conference Call and Webcast CHELMSFORD, Mass., Nov. 4, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2021 fourth quarter and year-end earnings which ended on September 30, 2021 on Wednesday, November 10, 2021 after the market closes. The Company will host a conference... Read more
CHELMSFORD, Mass., Nov. 3, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today announced that Frank Casal has been elected to its Board of Directors. Mr. Casal most recently served as Vice Chair, Audit for KPMG, LLP, the U.S. member firm of KPMG International (KPMGI). He joins the Brooks Board and Audit Committee, bringing deep... Read more
MENLO PARK, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2021. Record revenue reflects 6th straight quarter of sequential growth Revenue of $34.9 million, an 83% increase compared with $19.1 million in the prior year period. Placed 44 Sequel II/IIe systems during the... Read more
Revenue of $1.17 billion; 21% reported growth; 12% organic growth GAAP EPS from continuing operations of $1.11; Adjusted EPS of $2.31 Initiates Fourth Quarter Guidance and Raises Full Year Revenue and Earnings Guidance WALTHAM, Mass.–(BUSINESS WIRE)–Nov. 2, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial... Read more
Thermo Fisher Scientific Showcases Investment and Innovation During CPhI Worldwide 2021 Strategic expansions help to enable accelerated demand for new medicines and therapies WALTHAM, Mass., Nov. 2, 2021 /PRNewswire/ — At CPhI Worldwide 2021, Thermo Fisher Scientific will showcase its newest capabilities across its global pharma services network which help pharmaceutical and emerging biotech companies accelerate... Read more
Orders growth of 22% on a reported basis, 20% organically, from strong underlying demand across segments Revenue growth 4% on a reported basis, 2% organically Net income as a percentage of revenue of 9.0%, up 600 basis points; adjusted EBITDA margin of 17.9%, down 30 basis points Reported net income of $114 million or $0.63... Read more
Q3 2021 revenues of $608.9 million, up 19.1% year-over-year (yoy); organic growth of 17.8% Q3 2021 GAAP EPS of $0.57, up 63% yoy; non-GAAP EPS of $0.63, up 50% yoy Raising FY 2021 guidance significantly on strong demand for Bruker’s products and solutions BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced financial results for... Read more
Revenue of $742 million, up 26% year-over-year Non-GAAP net earnings of $155 million, up 45% year-over-year, and GAAP net income of $132 million, up 44% year-over-year Operating cash flow of $153 million, up 1% year-over-year, and free cash flow of $133 million, up 8% year-over-year ANDOVER, Mass., Read more
WALTHAM, Mass., Oct. 27, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended October 2, 2021. Third Quarter 2021 Highlights Third quarter revenue increased 9% to $9.33 billion. Third quarter GAAP diluted earnings per share (EPS) was $4.79. Third... Read more